{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:33:31Z","timestamp":1770975211780,"version":"3.50.1"},"reference-count":20,"publisher":"Media Sphere Publishing House","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2020]]},"DOI":"10.17116\/jnevro2020120051160","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T10:51:56Z","timestamp":1593859916000},"page":"160","source":"Crossref","is-referenced-by-count":6,"title":["Possibilities of using Mexidol in the complex therapy of mental disorders"],"prefix":"10.17116","volume":"120","author":[{"given":"V.K.","family":"Shamrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.S.","family":"Kurasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.V.","family":"Nechiporenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.","family":"Kolchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.V.","family":"Tsygan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro2020120051160-1","unstructured":"Jones PB, Buckley PF. Schizophrenia. Clinical guide. Moscow; 2008. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-2","unstructured":"Danilov DS. Antipsychotics of different clinical\/pharmacological groups in treatment of negative disorders in schizophrenia. Journal of neurology and psychiatry. 2014;9:116-123. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-3","doi-asserted-by":"crossref","unstructured":"Tacke B, Freistein H, Kempf H. Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam). Pharmakopsychiatrie neuropsychopharmakologie. 1975;8(2):82-89","DOI":"10.1055\/s-0028-1094446"},{"key":"key-10.17116\/jnevro2020120051160-4","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0777-x"},{"key":"key-10.17116\/jnevro2020120051160-5","unstructured":"Papazacharias A, Nardini M. The relationships between depression and cognitive deficits. Psychiatria Danubina. 2012;24 (suppl 1):179-182"},{"key":"key-10.17116\/jnevro2020120051160-6","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201611611145-57"},{"key":"key-10.17116\/jnevro2020120051160-7","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20151152111-15"},{"key":"key-10.17116\/jnevro2020120051160-8","unstructured":"Kurasov ES, Remizevich RS. Influence of Mexidol in combination with antidepressant therapy on sleep disorders in panic disorder in young people. Journal of neurology and psychiatry. 2013;2:33-38. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-9","unstructured":"Mishukova AYu. Application of the drug Mexidol in the treatment of acute intoxication with synthetic drugs and abstinent States as a result of their use. Mexidol in the clinic and experiment. Moscow; 2019:428-430. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-10","unstructured":"Diakonov AL. Mexidol as additional therapy in patients with continuous paranoid schizophrenia in the presence of tardive dyskinesia. Psychiatry and psychopharmacotherapy. 2011;4:28-32. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-11","unstructured":"Kosenko VG, Karagezyan EA, Luneva LV, Smolenko LF. Application of mexidol in psychiatric practice. Journal of neurology and psychiatry. 2006;6:38-41. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-12","unstructured":"Alfimova MV, Uvarova LG, Trubnikov VI. Psychological and brain mechanisms of speech Association disorders in schizophrenia. Social and clinical psychiatry. 2001;11(1):67-74. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-13","unstructured":"Uranova NA, Kolomeets NS, Vikhreva OV, Zimina IS, Rahmanova VI, Orlovskaya DD. Ultrastructural pathology of myelin fibers in schizophrenia. Journal of neurology and psychiatry. 2013;9:63-69. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-14","unstructured":"Govorin NV, Vasilieva AI. Neuromarkers and indicators of endothelial dysfunction in acute schizophrenia. Social and clinical psychiatry. 2011;21(1):29-33. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-15","unstructured":"Golenkov AV. Disorders of thinking and speech in patients with schizophrenia with deficient manifestations . Bulletin of psychiatry and psychology of Chuvashia. 2008;4:8-17. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-16","doi-asserted-by":"crossref","unstructured":"Savina T, Orlova V, Trubnikov V. Correlations between multy-level characteristics of schizophrenia pathogenesis in families. European College of Neuropsychopharmacology. 1998;8 (Suppl. 2):306","DOI":"10.1016\/S0924-977X(98)80607-X"},{"key":"key-10.17116\/jnevro2020120051160-17","doi-asserted-by":"crossref","unstructured":"Amodio DM, Master SL, Yee CM, Taylor SE. Neurocognitive components of the behavioral inhibition and activation systems: implications for theories of self-regulation. Psychophysiology. 2008;45(1):11-19","DOI":"10.1111\/j.1469-8986.2007.00609.x"},{"key":"key-10.17116\/jnevro2020120051160-18","unstructured":"Shapovalov DL. Application of Mexidol and its combination with dextran 40 for correction of negative symptoms and neurocognitive deficit in patients with paranoid schizophrenia. Bulletin of experimental biology and medicine. 2012;1:104-108. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-19","unstructured":"Karpov AM, Melnikov MA. Pharmacotherapeutic potential of the complex of drugs Mexidol and Cortexin for the treatment of patients with opioid addiction. Mexidol in the clinic and experiment. Moscow; 2019:422-427. (In Russ.)"},{"key":"key-10.17116\/jnevro2020120051160-20","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20171172153-63"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T06:13:00Z","timestamp":1723183980000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2020\/5\/1199772982020051160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["10.17116\/jnevro2020120051160"],"URL":"https:\/\/doi.org\/10.17116\/jnevro2020120051160","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}